Indonesia Caps Specialist Referrals for Diabetes Care at Primary Clinics
Indonesia's national health insurer now pushes type-2 diabetes care down to the puskesmas, the neighbourhood clinic that most patients reach on foot. The referral cap is a cost-control instrument, and it lands hardest in provinces where the nearest endocrinologist is a flight away.
Referral Caps Reshape Diabetes Care
BPJS Kesehatan, the social security agency that runs Indonesia's universal health coverage, has tightened the rules under which a puskesmas can send a patient to a hospital specialist. For type-2 diabetes, the clinic is expected to manage the case itself: confirm the diagnosis, start metformin, monitor blood sugar, and treat common complications. A referral upward needs a documented reason, not a patient's preference.
The stated aim is financial. Non-communicable diseases, diabetes among them, absorb a growing share of the claim budget each year, and hospital outpatient visits are far more expensive than a clinic consultation. By keeping stable patients at the primary level, the agency hopes to slow that growth without cutting the benefit package on paper.
The mechanism is a quota. Clinics have a ceiling on how many referrals they can issue in a period, and the number is monitored against their patient list. Emergency cases are exempt, but a routine request for an endocrinologist appointment is not. This is gatekeeping by design, and it changes what a patient can ask for.
Diabetes Burden and the Puskesmas Network
Indonesia sits high on the global list of countries by number of people living with diabetes, though estimates vary widely because most cases are undiagnosed. A large share of adults with raised blood sugar do not know it. That makes the puskesmas the front line by default, since it is where screening happens for most of the population.
The network is vast. Thousands of primary clinics are spread across the archipelago, staffed largely by general practitioners, nurses, and midwives rather than specialists. They provide basic screening, blood glucose testing, and first-line medication. In principle, that is enough to manage uncomplicated type-2 diabetes for years.
Specialist access is uneven. Java and Bali have dense hospital coverage. Eastern provinces such as Papua, Maluku, and East Nusa Tenggara have far fewer endocrinologists per person, and some districts have none at all. A referral cap that works as a nudge in Jakarta functions as a wall in Merauke.
The demographic pressure is not evenly distributed. Urban clinics in Java report growing caseloads as diets shift and activity falls, while some rural districts still struggle to fill their screening quotas. The same national policy therefore meets very different local realities, and the referral cap is felt differently depending on whether a clinic is overwhelmed by patients or by the absence of them.
How the Referral System Works
Under the tiered system, a patient must first be registered at a primary clinic, usually the one nearest their home address. That clinic becomes the gate for non-emergency specialist care. Without its referral letter, a hospital visit may not be covered by BPJS Kesehatan, and the patient can be billed as a private case.
The referral is valid for a defined period and for a named specialist or hospital department. If the specialist wants the patient back for follow-up, a new referral is needed. Patients who move between islands sometimes find their registration tied to an address they no longer use, which complicates continuity of care.
BPJS Kesehatan monitors referral data by clinic and by region, looking for outliers. A clinic that refers far more than its peers may be flagged for review. The agency has said it adjusts the rules based on this data, though the thresholds are not published in a form a patient can easily check.
For patients, the practical effect is that the first visit to a specialist often requires a return trip to the puskesmas for paperwork. That extra step is trivial in a city with good transport and a serious burden for someone who has travelled from a village. The system assumes a level of mobility that not all patients have.
Equity Concerns in Rural Areas
The sharpest objection comes from clinicians in the eastern provinces. A referral cap assumes the clinic can do what the hospital would have done, and that assumption fails when the clinic has no HbA1c testing, no insulin storage, and no dietitian. In those settings, the cap delays care rather than redirecting it.
Travel is the other cost. A patient in a remote district may need a boat and a bus to reach a hospital, plus accommodation for a companion. Even when a referral is granted, the out-of-pocket expense can exceed the value of the covered treatment. The cap reduces the number of letters without reducing the distance.
Stockouts compound the problem. Clinics report intermittent shortages of metformin and of glucose test strips, and insulin is harder still to keep in the cold chain. When the drug is not on the shelf, the patient is told to buy it privately, which defeats the purpose of coverage. A related piece on this site describes how training can outrun the supply chain, and the pattern is familiar here.
There is also a gender dimension that rarely enters the policy discussion. Women in rural households often carry the responsibility for cooking and for caring for others, and a day spent travelling to a hospital is a day of unpaid work lost. When the referral cap makes specialist care harder to reach, it is often women who absorb the cost by delaying their own treatment.
Provider Perspectives and Adaptation
Clinic staff describe a heavier workload without a matching increase in staffing. A general practitioner who once referred a difficult case now has to titrate medication, counsel on diet, and screen for eye and foot complications in a fifteen-minute slot. Training exists, but it competes with every other demand on the clinic's time.
Some puskesmas have responded by writing their own diabetes protocols, setting internal thresholds for when a referral is justified. These local rules help standardise care and make the quota defensible to reviewers. They also vary from district to district, so a patient's access depends on where they live.
Telemedicine offers a partial fix. A remote consultation with a specialist can resolve questions that would otherwise require travel, and some provinces have piloted this. It does not solve the need for an eye exam or a foot ulcer review, and connectivity is unreliable in many outer islands. This site has argued that training for a service model can lag behind the model itself, which is the risk here.
Where telemedicine has worked, it has usually been paired with a local champion—a nurse or doctor who takes responsibility for scheduling and follow-up. Without that human link, the equipment sits unused. The technology is not the constraint; the staffing model is.
What the Evidence Shows
Studies from other middle-income countries suggest that strong primary care can manage uncomplicated type-2 diabetes as well as hospitals, provided the clinic has reliable drug supplies and trained staff. The evidence is less clear when those conditions are missing. A cap on referrals without investment in primary capacity is a cut, not a reform.
BPJS Kesehatan has not published a full evaluation of the referral policy's effect on diabetes outcomes, and independent researchers face hurdles in accessing claims data. Without that evidence, the debate relies on clinic anecdotes and regional comparisons, which are suggestive but not conclusive. The agency says it monitors quality indicators, but the details are not public.
What is clear is that the policy shifts risk to patients and providers. If a clinic cannot deliver the care, the patient bears the consequence. If a doctor refers too many patients, the clinic faces scrutiny. The incentives are aligned toward under-referral, which may save money in the short term and cost more in complications later.
Practical Steps for Patients and Providers
Ask the puskesmas directly what diabetes services it provides, including whether it can test blood glucose and supply metformin without an extra charge. Knowing the clinic's capacity before a crisis saves a wasted trip.
Request a referral in writing if blood sugar stays uncontrolled after several months of treatment, or if there are signs of complications such as blurred vision, numbness in the feet, or a wound that will not heal. The request should name the clinical reason, since that is what the quota system reviews.
Check medication availability before leaving the clinic counter. If the drug is out of stock, ask for a written note and confirm where the nearest stocked facility is, so the gap is documented rather than absorbed privately.
Keep copies of every referral letter, prescription, and lab result. Continuity across clinics depends on paper the patient carries, and disputes over coverage are easier to resolve with a record of what was authorised and when.
Contact BPJS Kesehatan through its care centre or mobile app if a referral is refused without a stated clinical reason, or if a hospital demands payment for a service that should be covered. The agency handles coverage disputes, though resolution times vary. A related piece on training community health workers for screening shows how front-line capacity shapes outcomes in similar systems.
This article is informational and does not constitute personalised medical or financial advice. Patients should consult a qualified clinician about their own treatment.
